Poster presentations I

Session detail

PA-006
Plasma Mycobacterium tuberculosis Cell-Free DNA Assay: A Diagnostic Tool for Tuberculosis Lymphadenitis
Sosina Ayalew, Armauer Hansen Research Institute (AHRI), Ethiopia

PA-010
Novel Approaches for Developing a Highly Sensitive Molecular Assay for the Diagnosis of Tuberculosis
Clement Likhovole, Mount Kenya University, Kenya

PA-012
Diagnostic performance of ultrasensitive rapid diagnostic test for the detection of Plasmodium falciparum infections in asymptomatic individuals in Kisangani, Northeast Democratic Republic of Congo 
Dieu Merci Mbumba Lupaka, University of Health and Allied Sciences, Ghana

PA-023
Co-infection of high-risk human papillomavirus with hepatitis b virus, c.trachomatis and n.gonorrhea in young Tanzanian women 
Anifrid Mahenge, NIMR-Mbeya Medical Research Center, Tanzania

PA-046
Understanding oxygen concentrator failures in low resource settings: the role of dust and humidity 
Ernest Bwogi, Ernest Cook University, Uganda

PA-048
Severe anaemia in southern Benin: prevalence and clinical impact in referral hospitals
Landry Assongba, Institut de Recherche Clinique du Bénin (IRCB), Benin

PA-051
Prevalence of Chlamydia trachomatis and Self-Sampling Acceptability Among Women Living with HIV in Kisumu, Kenya
Martha Nyakambi, PHDA, Kenya

PA-054
Placental transmission of malaria: consequences for pregnancy outcomes and neonatal immunity
Joy Acha, Delta State University, Nigeria

PA-068
Impact of varying uptake of intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTP-SP) on prevalence of pregnancy-associated malaria in Nigeria
Ejiro Obrirhe, Delta State University Abraka, Nigeria

PA-086
Previous or current infection with SARS-CoV-2 infection and its impact on maternal and neonatal health outcomes in Benin: a sero-epidemiological study in pregnant women 
Manfred Accrombessi, Institut de Recherche Clinique du Benin, Benin

PA-097
Burden and associated factors of Plasmodium Malaria infections in southern Benin
Yannelle Dossou, Institut de Recherche Clinique du Bénin (IRCB), Benin

PA-119
Analysis of the spatiotemporal evolution of confirmed mpox cases in the Republic of Congo: before and during the 2023–2024 floods
Martin Herbas Ekat, Centre Hospitalier Universitaire de Brazzaville, Congo

PA-146
A phase III randomised, controlled, multi-centre trial to evaluate the efficacy of the R21/Matrix-M vaccine in African children against clinical malaria
Muanuzi Mutabuzi, Ifakara Health Institute, Tanzania

PA-189
Unraveling the Spatiotemporal Clustering of Malaria Incidence: Modelling a decade of epidemiological data in Jimma Zone, Oromia, Ethiopia 
Abdissa Biruksew Hordofa, Jimma University, Ethiopia

PA-200
Genetic markers associated with knock-down resistance in the Anopheles population in Madibou and Goma Tse-Tse, Republic of Congo 
Jacques Dollon Mbama Ntabi, Fcrm, Congo

PA-207
Evolving dynamics of whole-genome Influenza A/H3N2 viruses isolated in Cameroon from 2023-2024
Desmon Toutou Tsafack, Centre Pasteur du Cameroun, Cameroon

PA-219
Human ace2 and tmprss2 polymorphisms associated with susceptibility to Mycobacterium tuberculosis and SARS-CoV-2 co-infection in a Cameroonian cohort
Mary Kameni, University of Yaounde 1, Cameroon

PA-233
Overweight in children is associated with increased risk of Plasmodium spp.  infection in a rural area of Mali, West Africa 
Cheick Sangare, Université des Sciences et de Technologie de Bamako, Mali

PA-239
Older age associated with renal impairment among adolescents and young people receiving HIV treatment in Uganda and Tanzania
Benjamin Watyaba, Uganda Virus Research Institute, Eastern Africa Consortium for Clinical Research, Uganda

PA-244
Comprehensive analysis of molecular markers linked to antimalarial drug resistance in Plasmodium falciparum in Northern and Eastern Uganda 
Peter Olupot-Olupot, Mbale Clinical Research Institute (MCRI)/ Busitema University, Uganda

PA-252
Cost-effectiveness of home alcohol-based hand rub to prevent infant illness and death: the BabyGel trial 
Francis Okello, University of Bergen, Norway

PA-263
Results of a baseline cross section Cluster randomized survey of implementation research evaluating Severe malaria treatment with Rectal Artesunate and an ACT in Nchelenge, Zambia
Sebastian Hachizovu, Tropical Diseases Research Centre, Zambia

PA-267
Prediction models for Mtb infection among adolescent and adult household contacts in high TB incidence settings 
Edson Marambire, The Health Research Unit Zimbabwe, Biomedical Research and training Institute, Zimbabwe

PA-271
Genomic characterization of Dengue virus circulation in Ethiopia, 2022-2023 
Adugna Abera, Ethiopian Public Health Institute, Ethiopia

PA-278
The hidden challenge: hrp2/3 gene deletions and malaria diagnosis in Southern Ethiopia 
Bacha Tafa, Ethiopian Public Health Institute, Ethiopia

PA-292
Knowledge, perceptions and factors associated with adverse drug reaction reporting among people living with HIV at TASO Mulago 
Bushirah Mutesi, Uganda Virus Research Institute, Uganda

PA-295
Prevalence of maternal SARS-CoV-2 infection and effects on pregnancy outcomes in women from Gabon and Mozambique
Anete Mendes Muxlhanga, Manhiça Health Research Center, Mozambique

PA-303
AWAKE-Africa: African women advancing knowledge and equity in global health research through a community of practice 
Gloria Rukomeza, The Global Health Network, Rwanda

PA-307
Genomic characterization of a unique population of Leishmania tropica in a new emerging focus of cutaneous leishmaniasis in Somali region of Ethiopia 
Adugna Abera, Ethiopian Public Health Institute, Ethiopia

PA-317
Co-infections HIV, hepatitis B and COVID-19: frequencies, toxicity (liver and kidney) in pulmonary tuberculosis patients at Jamot Hospital in Yaoundé, Cameroon 
Diane Kamdem Thiomo, University of Yaoundé 1, Cameroon

PA-323
Ensuring sustainability and accessibility in digital public health technologies: the role of the nuvoteQ Foundation NPC 
Marina Lazaridis, nuvoteQ, South Africa

PA-326
Quality of Necator americanus third stage larvae as an investigational product for Controlled Human Infection in Gabon
Christine Ndong, CERMEL, Gabon

PA-328
Strengthening pathogens genomic surveillance using nanopore sequencing at the University of Yaoundé 1, Cameroon 
Francis Zeukeng, The Biotechnology Centre, University of Yaounde 1, Cameroon

PA-341
Implementing innovative strategies to enhance youth participation in the digital transformation of health in Africa: design, implementation, and evaluation of a youth-led designathon 
Victor Femi-Lawal, College of Medicine, University of Ibadan, Nigeria

PA-356
The TB vaccine development pathway: a tool from and for the TB community 
Marit Holleman, TBVI, Netherlands

PA-360
Trends and patterns of clinical trials in East Africa: analysis of a decade of data from the WHO international clinical trials registry platform 
Shiferaw Tilahun, Ethiopian Public Health Institute, Ethiopia

PA-370
Characterization of Hepatitis E Virus in vulnerable populations in Ogbomoso: insights from Pregnant Women, People Living with HIV, and Pigs 
Adenike Olayinka, Humbodlt Research Hub- Center for Emerging and Re-emerging Infectious Disease (HRH-CERID), Nigeria

PA-387
Causes, severity and outcome of acute febrile illnesses in sub-Saharan Africa: A multi-center prospective observational study
Bernard Kikaire, Uganda Virus Research Institute and the African Coalition for Epidemic Research Response and Training (ALERRT), Uganda

PA-389
High rate of indeterminate results for rifampicin-resistance in pulmonary tuberculosis patients at a District Hospital in Ethiopia: implications for programmatic use of Xpert MTB/RIF Ultra
Mulualem Tadesse Jano, Jimma University, Ethiopia

PA-408
Assessing fecal coliforms and escherichia coli in drinking water sources: a study in cholera hotspots of Lusaka, Zambia 
Robby Kapikila, Center For Infectious Disease Research in Zambia, Zambia

PA-415
“If your CD4 count lowers, that is when you are similar to a person that is non-existent” Perceptions around advanced HIV disease in South Africa
Thembelihle Pita, Human Sciences Research Council, South Africa

PA-427
Contextual and cognitive challenges in diagnosing infectious diseases: design implications for point-of-care clinical decision support in Africa
Faiza Umar Bawah, University of Ghana, Ghana

PA-435
Core Genome Phylogeny of V. cholerae reveals inter-regional similarity and lineage diversity in the Great Lakes Region
Vanessa Onyonyi, Kenya Medical Research Institute, Kenya

PA-439
How to get close to real life while doing research: Feedback from an implementation science study on prevention of post-natal HIV transmission in Zambia 
Mwiya Mwiya, University Teaching Hospital, Zambia

PA-442
Comprehensive phylogenomic analysis of Mycobacterium tuberculosis in Ethiopia
Betselot Ayano, Ethiopian Public Health Institute, Ethiopia

PA-468
Strengthening ethical and regulatory frameworks in Africa through virtual learning environments: the experience of the training centre of The Global Health Network
Trudie Lang, The Global Health Network, United Kingdom

PA-477
Longitudinal patterns and predictors of linear growth impairments among adolescents living with HIV receiving antiretroviral therapy in Zimbabwe and Zambia 
Tafadzwa Madanhire, Biomedical Research and Training Institute, The Health Research Unit, Zimbabwe

PA-489
Cytokines profiling, HIV-1 DNA levels and viral-replication among antiretroviral treatment-experienced adolescents in Cameroon: paving the way toward pediatric HIV functional cure
Aude Christelle Ka'e, Chantal Biya International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Cameroon

PA-497
Evolution of the HIV Epidemic in Cabo Verde from 2000 to 2023
Sandra Brito, Universidade de Cabo Verde; Ministério da Saúde de Cabo Verde, Cape Verde

PA-500
Unraveling the genetic tapestry: exploring the impact of drug resistance gene mutations on treatment outcomes in multidrug-resistant tuberculosis patients in Tanzania 
Bugwesa Zablon Katale, Tanzania Commission for Science and Technology, Tanzania

PA-554
HIV and HBV co-infections among patients with active TB disease attending Attending DOT Centers in Southwestern Nigeria
Adekunle Olowe, Ladoke Akintola University of Technology, Nigeria

PA-556
Controlled human hookworm infection for accelerated development of drugs and vaccines in Africa 
Ayò̩délé Àlàbi, Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon

PA-562
Sub-Saharan Africa febrile patients care pathway
Menan Gérard Kouame, Programme PAC-CI, Cote d'Ivoire

PA-563
Association of environmental enteric dysfunction (EED), growth, and micronutrient biomarkers with stunting and shigella infection in under-five children in Lusaka, Zambia 
Mwelwa Chibuye, Center for Infectious Diseases Research in Zambia (CIDRZ), Zambia

PA-605
Clinical presentations, risk factors, maternal and neonatal outcomes among COVID-19 infected and non-infected pregnant women in Nigeria 
David Eko, Federal Ministry of Health and Social Welfare, Nigeria

PA-627
Genomic analysis and antimicrobial resistance of vibrio cholerae isolated during Zambia's 2023 cholera epidemic 
Harriet Ng'ombe, Centre for Infectious Disease Research, Zambia

PA-652
Qualification of LC MS/MS Methods for the Determination of Flucytosine (5 FC) and 5 Fluorouracil (5 FU) in Different Human Matrices
Kopano Sease, FARMOVS, South Africa

PA-673
Culturally sensitive approaches to informed consent in clinical research, The Gambia
Daisy Clara H. Williams, Medical Research Council The Gambia at LSHTM, Gambia

PA-683
Seasonal transmission dynamics, infection complexity, and parasite relatedness of Plasmodium falciparum from two different ecological zones in Northwest Ethiopia
Ayalew Jejaw Zeleke, University of Gondar, Ethiopia

PA-686
Africa-Swiss Science Diplomacy: A Catalyst for Innovation, Prosperity and Stability
Flory Luzolo Khote, University of Kinshasa, Democratic Republic of the Congo

PA-697
Strengthening clinical trial capacity in Ethiopia: Lessons learned from the PREGART clinical trial implementations 
Abel Gedefaw Ali, Hawassa University, Ethiopia

PA-704
Health inequality impact of providing alcohol-based hand rub to mothers enrolled in the BabyGel trial in Eastern Uganda: a cluster randomised controlled trial
Francis Okello, University of Bergen, Norway; Busitema University, Uganda

PA-712
The potential of a customised digital tool in improving retention in care among breastfeeding women living with HIV in Kilimanjaro, Tanzania
Alan Mtenga, Kilimanjaro Clinical Research Institute, Tanzania

PA-722
Psychosocial life indicators predictive of poor medication adherence among adolescents and young people living with HIV (AYPLHIV) in Rwanda
Jean Berchmans NIYIBIZI, College of Medicine and Health Sciences, University of Rwanda, Rwanda

PA-732
Serological evidence supports the transmission of clade Ib MPXV by sex workers and spread within households in South Kivu, DRC 
Luca Zaeck, Department of Viroscience, Erasmus MC, Netherlands

PA-743
Effect of short message service reminders, phone calls and transport incentives on diagnosis completion among presumptive patients in Uganda: a randomised controlled trial-MILEAGE4TB
Esther Buregyeya, Makerere University School of Public Health, Uganda

PA-757
Effectiveness of Enhanced Adherence Counselling Among Adolescents Receiving Dolutegravir-Containing Regimens With Detectable Viremia in Cameroon: Optimizing Virological Outcomes in Paediatric Settings
Alex Durand Nka, Chantal Biya International Reference Centre for Research on HIV/AIDS prevention and Management (CIRCB), Cameroon

PA-760
Diagnostic Accuracy of Mycobacterium tuberculosis Stool Ultra in detecting TB among Adult People Living with HIV: A Multicentre Study 
George Kasule, Department of Medical Microbiology, College of Health Sciences Makerere University Uganda, Uganda

PA-774
The Impact of Vaccination and Isolation Strategies on Mpox Dynamics in South Kivu: Modelling Approach 
Gloria Salome Shirima, Epidemic Response Lab, AIMS RIC, Rwanda

PA-775
Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine 2 (TMPRSS2) genetic polymorphisms association with COVID-19 severity: a retrospective cohort study from Senegal
Dieynaba Diallo, Institut Pasteur,Senegal

PA-780
Strengthening pharmacovigilance in Nigeria: enhancing regulatory frameworks and drug safety systems
Onyinye Akunne, Qua Pillar Health Research Foundation, Nigeria

PA-797
Clinical evaluation of computer-aided digital X-ray detection of pulmonary tuberculosis during community-based screening/active case-finding: a case-control study
Ashley Chizema, Biomedical Research and Training Institute, Zimbabwe

PA-809
Body mapping the intersecting axes of motivations and stressors that Community Health Workers (CHWs) experience and the implication for their Mental well-being in Kenya
Victoria Akoth Ochwal, LSTM, Kenya

PA-811
Challenges and lessons learnt in the deployment of new health technologies into the health system in Ghana: Experiences from the SAVING Consortium, Ghana
Margaret Gyapong, University of Health and Allied Sciences, Ghana

PA-827
Ghanain women's perception on causes, prevention and treatment of anemia in pregnancy and its impact on their health seeking behaviours: an ethnographic approach
Mawulom Kuatewo, University of Health and Sciences, Ghana

PA-833
Application of a multiplex serological assay for the integrated surveillance of neglected tropical diseases: preliminary results from Senegal
Aissatou Diagne, Institut Pasteur of Dakar, Senegal

PA-855
Genomic Analysis of Vibrio cholerae in Africa: quantifying antimicrobial resistance and implications for public health
Rajiha Ibrahim, Ethiopian Public Health Institute, Ethiopia